These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7601705)

  • 21. Effectiveness of two benzathine cloxacillin formulations for treatment of naturally occurring infectious bovine keratoconjunctivitis.
    George LW; Keefe T; Daigneault J
    Am J Vet Res; 1989 Jul; 50(7):1170-4. PubMed ID: 2774340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged occurrence of Moraxella bovis infection on a restricted heifer farm.
    Iwasa M; Kawada A; Yorita M; Ishiguro N; Shinagawa M
    J Vet Med Sci; 1994 Jun; 56(3):429-32. PubMed ID: 7948367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility of Moraxella bovis.
    Shryock TR; White DW; Werner CS
    Vet Microbiol; 1998 Apr; 61(4):305-9. PubMed ID: 9646479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of intrapalpebral and intramuscular application of oxytetracycline in a natural outbreak of infectious bovine kertoconjunctivitis (IBK) in calves.
    Starke A; Eule C; Meyer H; Im Winkel C; Verspohl J; Rehage J
    Dtsch Tierarztl Wochenschr; 2007 Jun; 114(6):219-24. PubMed ID: 17642322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis pilin-Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Bonifacio RG; Ball LM; Hess JF
    Vet Microbiol; 2007 Dec; 125(3-4):274-83. PubMed ID: 17656049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An investigation of colonization of the conjunctival sac of sheep by bacteria and mycoplasmas.
    Dagnall GJ
    Epidemiol Infect; 1994 Jun; 112(3):561-7. PubMed ID: 8005222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infectious bovine keratoconjunctivitis (pinkeye).
    Angelos JA
    Vet Clin North Am Food Anim Pract; 2015 Mar; 31(1):61-79, v-vi. PubMed ID: 25576389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moraxella bovis pathogenicity: an update.
    Postma GC; Carfagnini JC; Minatel L
    Comp Immunol Microbiol Infect Dis; 2008 Nov; 31(6):449-58. PubMed ID: 18514312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The concentration of penicillin in bovine conjunctival sac fluid as it pertains to the treatment of Moraxella bovis infection. (II) Topical application.
    Abeynayake P; Cooper BS
    J Vet Pharmacol Ther; 1989 Mar; 12(1):31-6. PubMed ID: 2704058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the clinical efficacy of subconjunctival injection of clindamycin in the treatment of naturally occurring infectious bovine keratoconjunctivitis.
    Senturk S; Cetin C; Temizel M; Ozel E
    Vet Ophthalmol; 2007; 10(3):186-9. PubMed ID: 17445081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analyses of lipopolysaccharides, outer membrane proteins and DNA fingerprints reveal intraspecies diversity in Moraxella bovis isolated in Argentina.
    Prieto CI; Aguilar OM; Yantorno OM
    Vet Microbiol; 1999 Dec; 70(3-4):213-23. PubMed ID: 10596805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review and meta-analysis of the antibiotic treatment for infectious bovine keratoconjunctivitis: an update.
    Cullen JN; Yuan C; Totton S; Dzikamunhenga R; Coetzee JF; da Silva N; Wang C; O'Connor AM
    Anim Health Res Rev; 2016 Jun; 17(1):60-75. PubMed ID: 27427193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Moraxella bovis biomass production in a bench-top fermentor].
    González RD; Oberti ER
    Rev Latinoam Microbiol; 1994; 36(3):177-81. PubMed ID: 7709093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serologic cross-reactivity of Australian Moraxella bovis to vaccinal bacterin strains as determined by competitive ELISA.
    McConnel CS; Shum L; Gleeson BL; House JK
    Aust Vet J; 2008 Apr; 86(4):124-9. PubMed ID: 18363984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Hess JF; George LW
    Vaccine; 2004 Dec; 23(4):537-45. PubMed ID: 15530703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of serum antibodies to Moraxella bovis in cattle in Nigeria.
    Makinde AA; Ezeh AO; Onoviran O; Umo I
    Br Vet J; 1985; 141(6):643-6. PubMed ID: 4063787
    [No Abstract]   [Full Text] [Related]  

  • 37. Relatedness of cytotoxins from geographically diverse isolates of Moraxella bovis.
    Angelos JA; Ball LM
    Vet Microbiol; 2007 Oct; 124(3-4):382-6. PubMed ID: 17540518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of different dosage levels and administration routes of tilmicosin in a natural outbreak of infectious bovine keratoconjunctivitis (pinkeye).
    Zielinski GC; Piscitelli HG; Perez-Monti H; Stobbs LA; Zimmermann AG
    Vet Ther; 2002; 3(2):196-205. PubMed ID: 19750751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infectious keratoconjunctivitis in free-ranging mule deer (Odocoileus hemionus) from Zion National Park, Utah.
    Taylor SK; Vieira VG; Williams ES; Pilkington R; Fedorchak SL; Mills KW; Cavender JL; Boerger-Fields AM; Moore RE
    J Wildl Dis; 1996 Apr; 32(2):326-30. PubMed ID: 8722272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine against infectious bovine keratoconjunctivitis: a new approach to optimize the production of highly piliated Moraxella bovis cells.
    Prieto CI; Bosch A; Zielinski G; Cúneo J; Yantorno OM
    Vaccine; 2008 Dec; 26(51):6542-9. PubMed ID: 18852003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.